KR101217944B1 - A manufacturing method of lacquer tea bag - Google Patents
A manufacturing method of lacquer tea bag Download PDFInfo
- Publication number
- KR101217944B1 KR101217944B1 KR1020110063621A KR20110063621A KR101217944B1 KR 101217944 B1 KR101217944 B1 KR 101217944B1 KR 1020110063621 A KR1020110063621 A KR 1020110063621A KR 20110063621 A KR20110063621 A KR 20110063621A KR 101217944 B1 KR101217944 B1 KR 101217944B1
- Authority
- KR
- South Korea
- Prior art keywords
- lacquer
- powder
- tea bag
- manufacturing step
- tea
- Prior art date
Links
- 239000004922 lacquer Substances 0.000 title claims abstract description 51
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 40
- 241001122767 Theaceae Species 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 49
- 244000269722 Thea sinensis Species 0.000 claims abstract description 43
- 235000013616 tea Nutrition 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 19
- 241000202807 Glycyrrhiza Species 0.000 claims abstract description 13
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 13
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 13
- 229940010454 licorice Drugs 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 10
- 235000009569 green tea Nutrition 0.000 claims abstract description 9
- 238000004806 packaging method and process Methods 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 238000010298 pulverizing process Methods 0.000 claims abstract description 5
- 241000411851 herbal medicine Species 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 9
- 241000282374 Puma concolor Species 0.000 claims description 7
- 238000010276 construction Methods 0.000 claims description 7
- 229910052571 earthenware Inorganic materials 0.000 claims description 5
- 239000010865 sewage Substances 0.000 claims description 5
- 239000002023 wood Substances 0.000 claims description 5
- 244000044283 Toxicodendron succedaneum Species 0.000 abstract description 10
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 231100000419 toxicity Toxicity 0.000 abstract description 6
- 230000001988 toxicity Effects 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 3
- 230000003472 neutralizing effect Effects 0.000 abstract description 2
- 241000282461 Canis lupus Species 0.000 abstract 2
- 241000212948 Cnidium Species 0.000 abstract 2
- 241000207901 Cuscuta Species 0.000 abstract 2
- 241000146384 Glaux Species 0.000 abstract 2
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 244000197580 Poria cocos Species 0.000 abstract 2
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 2
- 241001618264 Rubus coreanus Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241001127714 Amomum Species 0.000 abstract 1
- 241001346320 Amomum villosum var. xanthioides Species 0.000 abstract 1
- 235000016500 Amomum xanthioides Nutrition 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- RMTXUPIIESNLPW-UHFFFAOYSA-N 1,2-dihydroxy-3-(pentadeca-8,11-dienyl)benzene Natural products CCCC=CCC=CCCCCCCCC1=CC=CC(O)=C1O RMTXUPIIESNLPW-UHFFFAOYSA-N 0.000 description 3
- QARRXYBJLBIVAK-UEMSJJPVSA-N 3-[(8e,11e)-pentadeca-8,11-dienyl]benzene-1,2-diol;3-[(8e,11e)-pentadeca-8,11,14-trienyl]benzene-1,2-diol;3-[(8e,11e,13e)-pentadeca-8,11,13-trienyl]benzene-1,2-diol;3-[(e)-pentadec-8-enyl]benzene-1,2-diol;3-pentadecylbenzene-1,2-diol Chemical compound CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O.CCCCCC\C=C\CCCCCCCC1=CC=CC(O)=C1O.CCC\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.C\C=C\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.OC1=CC=CC(CCCCCCC\C=C\C\C=C\CC=C)=C1O QARRXYBJLBIVAK-UEMSJJPVSA-N 0.000 description 3
- IYROWZYPEIMDDN-UHFFFAOYSA-N 3-n-pentadec-8,11,13-trienyl catechol Natural products CC=CC=CCC=CCCCCCCCC1=CC=CC(O)=C1O IYROWZYPEIMDDN-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 240000001987 Pyrus communis Species 0.000 description 3
- 235000014443 Pyrus communis Nutrition 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- DQTMTQZSOJMZSF-UHFFFAOYSA-N urushiol Natural products CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O DQTMTQZSOJMZSF-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 240000007643 Phytolacca americana Species 0.000 description 2
- 235000009074 Phytolacca americana Nutrition 0.000 description 2
- 240000003152 Rhus chinensis Species 0.000 description 2
- 235000014220 Rhus chinensis Nutrition 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/22—Drying or concentrating tea extract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/808—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package for immersion in the liquid to release part or all of their contents, e.g. tea bags
Abstract
Description
본 발명은 옻티백 제조방법에 관한 것으로서, 특히 옻나무의 독성을 제거한 후 옻나무와 한약재가 인체에 유익한 효능을 제공할 수 있도록 하는 옻티백 제조방법에 관한 것이다.
The present invention relates to a lacquer tea bag manufacturing method, and in particular to a lacquer tea bag manufacturing method to remove the toxicity of the lacquer and lacquer and herbal medicine to provide a beneficial effect on the human body.
옻나무는 칠기의 재료나 방부제, 살충제 등으로 이용되어 왔으며, 한의학에서 옻나무는 소화를 돕고 어혈과 염증을 풀어주며 피를 맑게 하고 균을 죽일 뿐 아니라 소변을 잘 나오게 하고 몸을 따뜻하게 하는 효능이 있다고 알려져, 신경통, 관절염, 위장병, 간병, 늑막염, 골수염, 적병과 같은 질환에 처방해 왔다. 또한, 민간에서는 보양효과가 있다고 알려져, 옻닭과 같은 특수한 옻 함유 요리를 보양식으로 섭취하고 있다.Lacquer tree has been used as a material for lacquer ware, as an antiseptic and insecticide, and in oriental medicine, lacquer tree is known to be effective in helping digestion, releasing blood and inflammation, clearing blood, killing bacteria, making urine well and warming the body. It has been prescribed for diseases such as neuralgia, arthritis, gastrointestinal disease, caring, pleurisy, osteomyelitis, and redness. In addition, in the private sector, it is known to have a rehabilitation effect, and special lacquer-containing dishes such as lacquered chicken are consumed as a supplement.
그러나, 옻은 위와 같은 다양한 효능을 가진 반면에 우루시올이라는 독성분을 지니고 있어, 자칫 잘못 섭취를 하게 되면 알러지가 나타나는 부작용이 발생하므로 일반적으로 옻의 유효성분을 섭취하여 그 효능을 얻고자 할 때에는 우루시올이라는 독성분을 제거해야만 한다.
However, lacquer has various effects as described above and has a toxic component called urushiol, so if you inadvertently ingest it, allergic side effects occur. Therefore, when you want to get the efficacy of the active ingredient of urushiol, urushiol Toxic must be removed.
본 발명은 상기한 종래기술의 문제점을 해결하기 위하여 안출된 것으로서, 옻나무분말과 한약재분말을 혼합하여 한약재분말이 옻나무의 독성을 중화시킴으로써 옻나무와 한약재가 상승작용을 일으켜 인체에 유익한 효능을 제공할 수 있는 옻티백 제조방법을 제공하는데 그 목적이 있다.
The present invention has been devised to solve the above problems of the prior art, by mixing the lacquer powder and the herbal medicine powder neutralizes the toxicity of the lacquer wood, so the lacquer and the herbal medicine can provide a beneficial effect on the human body The purpose of the present invention is to provide a lacquer tea bag.
상기한 과제를 해결하기 위한 본 발명에 의한 옻티백 제조방법은 옻나무의 목질, 뿌리, 씨앗 및 잎줄기를 건조한 후 압착하여 분쇄함으로써 옻나무분말을 만드는 옻나무분말 제조단계와; 천궁, 하수오, 공사인, 산사자, 숙지황, 토사자, 백복령, 원지, 복분자, 녹차 및 감초를 건조한 후 분쇄하여 한약재분말을 만드는 한약재분말 제조단계와; 상기 옻나무분말 제조단계에서 만들어진 옻나무분말과 상기 한약재분말 제조단계에서 만들어진 한약재분말을 1:1의 중량비로 혼합하여 혼합물을 만드는 혼합물 제조단계와; 상기 혼합물 제조단계에서 만들어진 혼합물을 티백에 수납하는 티백포장단계;로 구성된다.
Lacquer tea bag manufacturing method according to the present invention for solving the above problems is the lacquer powder manufacturing step of making a lacquer powder by drying the wood, roots, seeds and leaf stem of the lacquer and then crushed by pressing; Chinese herbal medicine powder manufacturing step of making medicinal herb powder by drying and pulverizing Cheongung, Sewao, construction worker, mountain lion, Sujijihwang, earthenware, Baekbokyeong, Wonji, Bokbunja, green tea and licorice; A mixture manufacturing step of mixing the lacquer powder made in the lacquer powder manufacturing step and the herbal medicine powder made in the herbal medicine powder manufacturing step in a weight ratio of 1: 1; Tea bag packaging step of receiving the mixture made in the mixture manufacturing step in a tea bag; consists of.
상기와 같이 구성되는 본 발명의 옻티백 제조방법은 한약재가 옻의 독성을 중화시킴으로써 인체에 전혀 해를 주지 않으면서도 옻의 유익한 효능과 한약재의 유익한 효능을 인체에 제공할 수 있는 이점이 있다.
Lacquer tea bag manufacturing method of the present invention is configured as described above has the advantage that can provide the beneficial effect of the lacquer and the beneficial effect of the herbal medicine to the human body without any harm to the human body by neutralizing the toxicity of the lacquer.
도 1은 본 발명에 의한 옻티백 제조방법을 보인 블록도.1 is a block diagram showing a lacquer tea bag manufacturing method according to the present invention.
이하, 본 발명에 의한 옻티백 제조방법의 실시 예를 첨부된 도면을 참조하여 상세히 설명한다.Hereinafter, with reference to the accompanying drawings, an embodiment of a lacquer tea bag manufacturing method according to the present invention will be described in detail.
도 1은 본 발명에 의한 옻티백 제조방법을 보인 블록도이다.
1 is a block diagram showing a method for manufacturing a lacquer tea bag according to the present invention.
본 발명에 의한 옻티백 제조방법은 옻나무분말 제조단계(S10)와, 한약재분말 제조단계(s20)와, 혼합물 제조단계(S30) 및 티백포장단계(S40)로 구성된다.
Lacquer tea bag manufacturing method according to the present invention comprises a lacquer powder manufacturing step (S10), a herbal medicine powder manufacturing step (s20), a mixture manufacturing step (S30) and tea bag packaging step (S40).
상기 옻나무분말 제조단계(S10)는 옻나무의 목질, 뿌리, 씨앗 및 잎줄기를 건조기에서 인공건조하거나 태양광에서 자연건조한 후, 이 건조된 옻나무의 목질, 뿌리, 씨앗 및 잎줄기를 압착하여 분쇄함으로써 옻나무분말을 만드는 과정이다.
The lacquer powder manufacturing step (S10) by artificially drying the wood, roots, seeds and leaf stems of the lacquer in a dryer or natural drying in sunlight, by pressing and grinding the wood, roots, seeds and leaf stems of the dried lacquer It is the process of making sumac powder.
상기 한약재분말 제조단계(S20)는 천궁, 하수오, 공사인, 산사자, 숙지황, 토사자, 백복령, 원지, 복분자, 녹차 및 감초를 건조한 후 분쇄하여 한약재분말을 만드는 과정이다.The Chinese herbal medicine powder manufacturing step (S20) is a process of making Chinese herbal medicine powder by drying and pulverizing Cheonggung, sewage, construction workers, mountain lions, sage, sulfur, earth and sand, baekbokyeong, Wonji, bokbunja, green tea and licorice.
이러한 한약재분말 제조단계(S20)에서는 천궁, 하수오, 공사인, 산사자, 숙지황, 토사자, 백복령, 원지, 복분자, 녹차 및 감초를 각각 동일한 중량을 사용하고, 이 동일한 중량의 한약재들을 건조하여 분쇄한 후 모두 혼합하여 한약재분말을 만든다.
In the Chinese herbal medicine powder manufacturing step (S20), the same weight of Cheonggung, Sewao, construction worker, mountain lion, Sukjihwang, earthenware, Baekbokryeong, Wonji, Bokbunja, green tea and licorice, respectively, after drying the same weight of herbal medicines Mix all to make Chinese herbal medicine powder.
여기서, 본 발명에 사용되는 다수의 한약재료에 대한 효능을 간단히 살펴보면 다음과 같다.Here, a brief look at the efficacy of a number of herbal ingredients used in the present invention.
천궁은 진정,진통,강장에 효능이 있어 두통,빈혈증,부인병 등에 효능이 있는 것으로 알려져 있으며, 특히 부인병에 효능이 탁월하여 혈을 돌게 해주고 월경을 고르게 해주며 풍을 사라지게 하는 효능이 있다.Cheonggung is known to be effective in calming, pain and tonic, and is effective in headaches, anemia and women's diseases. Especially, it is effective in gynecological diseases to make blood flow, even menstruation, and vanish.
하수오는 배박덩굴 또는 박주가리라는 덩굴성 식물로서 약성이 강한 약재로 알려져 있다. 이러한 하수오는 빈혈로 어지럽거나 머리카락이 일찍 세어서 흰 경우 또는 허리나 다리가 약하고 시릴 때 처방하고 간과 신장의 기능을 활성화하고 생식기능을 강화하는 것으로 알려져 있다.Sewage is a vine-like plant called Pear vine or Pakjugari, which is known as a strong medicinal herb. This sewage is known to prescribe when anemia is dizzy or when hair is prematurely white or when the lower back or legs are weak and cold, activating liver and kidney function and enhancing reproductive function.
공사인은 베트남이나 태국, 인도와 같은 열대지방에서 자라는 축사라는 식물의 씨를 말린 것으로, 맛은 맵고 성질은 따뜻하다. 이것은 땀을 내게 하고 기를 잘 통하게 하며, 비와 위의 기능을 세게 하고 습을 없애며, 토하는 것을 멈추게 하는 효능을 갖는 것으로 알려져 있다.The construction worker dried seeds of a barn, which grows in tropical regions such as Vietnam, Thailand, and India. The taste is spicy and warm. It is known to have the effect of sweating and chewing, hardening rain and stomach functions, eliminating moisture, and stopping vomiting.
산사자는 산사육, 찔광나무, 찔광이, 애광나무, 동배나무 등의 속명이 있는 식물로서, 과당, 포도당, 주석산, 비타민 C가 풍부하여 건강유지, 피로회복, 변비 등에 좋고, 건위와 소화불량, 식욕부진, 위산결핍증 또는 위산과다증에 효과가 좋으며, 설사와 생리통, 동상, 건위, 요통, 장출혈 등에도 약리적 효능이 우수한 것으로 알려져 있다.Mountain Lion is a genus of cultivated plants such as mountain cultivation, poke, poke, pear tree, and pear tree, and is rich in fructose, glucose, tartaric acid, and vitamin C. It is known to be effective against sluggish, gastric acid deficiency or hyperacidity, and has excellent pharmacological effects on diarrhea, menstrual pain, frostbite, dry stomach, low back pain and intestinal bleeding.
숙지황은 맛은 달면서도 쓴맛이 돌고 따뜻한 성질이 있어 혈을 보(補)하고 기운을 돋우며, 허리와 무릎이 시리고 아픈 증상이나 월경이상, 어지럼증 등을 치료하고 머리를 검게 하는 효능이 있는 것으로 알려져 있다.Sukjiwang is known for its sweetness and bitter taste and warm nature, which helps to cure blood and invigorate, treat the soreness of the lower back and knee, painful dysmenorrhea, dizziness, and blacken the head. have.
토사자는 주로 간과 신장을 보호하며 눈을 밝게 해주고, 양기(陽氣)를 도우며 신장 기능을 튼튼하게 해주는 약재로 알려져 있다. 또한, 뼈를 튼튼하게 해주고 허리힘을 세게 해주며, 신장 기능이 허약하여 허리와 무릎이 시리고 아픈 것에 효과가 있는 것으로 알려져 있다. 그리고, 오줌소태와 소변을 잘 보지 못하는 질병과 설사를 낫게 하며 당뇨병 치료에도 효과가 있는 것으로 알려져 있다. Tosa is known as a medicine that mainly protects the liver and kidneys, brightens the eyes, helps yang (yang 氣), and strengthens the kidney function. In addition, it strengthens the bones and strengthens the waist strength, weak kidney function is known to be effective in cold and painful waist and knee. In addition, it is known to be effective in the treatment of diabetes and diarrhea, which are difficult to pee and urinate.
백복령은 복령의 균핵을 건조시킨 것으로서, 폐경(肺經), 비경(脾經), 심경(心經), 신경(腎經), 방광경(膀胱經)에 작용하여 비장을 보하고 가래를 삭이며 정신을 안정시키는 것으로 알려져 있다. 여러 약리실험 결과에 의하면 이뇨작용과 혈당량을 낮추는 작용, 진정작용 등을 하는 것으로 밝혀졌으며 면역 부활작용을 하는 것으로도 알려져 있다. 위, 간, 이자, 신장 등의 질병에도 탁월한 효과가 있는 것으로 알려져 있으며, 질병을 앓고 난 후 허약한 사람이나 만성 위장병 환자 등의 치료를 위한 약재로 이용된다.Baekbok-ryeong is the dried core of Bokryeong, and it works on menopause, parenteral, heart, nerve and bladder to protect the spleen and sputum It is known to stabilize. Several pharmacological experiments have been shown to act as a diuretic, blood sugar lowering, sedation, and also known as immune resurrection. It is known to have an excellent effect on diseases such as stomach, liver, interest, kidney, etc., and is used as a medicine for the treatment of a weak person or a chronic gastrointestinal patient after suffering a disease.
원지는 심신불안 및 잘 놀라고 잠을 못자는 증상 및 건망증 등에 효과가 있는 것으로 알려져 있고, 응혈작용이 강하여 혈압을 내리는 것으로 알려져 있다.The base is known to be effective in mind and body anxiety, sleep and sleep symptoms and forgetfulness, and is known to lower blood pressure due to the strong coagulation action.
복분자는 신장기능을 튼튼하게 하고 눈을 밝게 하여 성기능과 야뇨증에 효과가 있으며, 항염작용, 항산화작용, 항헬리코박터 파이로리작용이 있는 것으로 알려져 있다.Bokbunja is known to have strong kidney function and brighten eyes, which is effective in sexual function and nocturnal enuresis, and has anti-inflammatory, antioxidant and anti-Helicobacter pylori effects.
녹차는 고혈압, 당뇨 등의 성인병 예방에서 다이어트에 이르기까지 많은 효능이 있으며, 동맥경화를 일으키는 콜레스테롤의 상승을 억제하는 작용이 있는 것으로 알려져 있다.Green tea has a lot of efficacy from the prevention of adult diseases, such as hypertension, diabetes, and diet, and is known to have an effect of suppressing the rise of cholesterol causing arteriosclerosis.
감초는 콩과의 다년생 초본으로 한방에서 모든 약재와 조화를 이루면서 효능을 증가시킬 뿐만 아니라 완화, 진통약으로 각종 동통 및 급박증상을 완화하는데 사용되고, 그 자체가 독을 중화시키는 약성이 있다. 예를 들면, 감초는 간장을 보호하고 간기능을 원활하게 하여 피로를 조절하는 약효가 있어서, 감초를 복용하면 그 해독작용에 의해 간의 부담이 경감된다. 또한, 감초는 항염증과 항알레르기반응작용을 보이고, 아세틸콜린에 대해 길항하는 작용을 나타내며, 아드레날린의 강심작용을 증강시키는 효과가 있다.
Licorice is a perennial herb that is a perennial herb and is used to alleviate various pain and urgency as well as to increase efficacy in harmony with all herbs in oriental medicine, and has the weakness to neutralize poison itself. For example, licorice has the effect of protecting the liver and smoothing the liver and regulating fatigue, and taking licorice reduces the burden on the liver by its detoxification. In addition, licorice shows anti-inflammatory and anti-allergic reactions, antagonistic action against acetylcholine, and has the effect of enhancing the cardiac action of adrenaline.
상기 혼합물 제조단계(S30)는 상기 옻나무분말 제조단계(S10)에서 만들어진 옻나무분말과 상기 한약재분말 제조단계(S20)에서 만들어진 한약재분말을 1:1의 중량비로 혼합하여 혼합물을 만드는 과정이다. 이렇게 옻나무분말과 복수개의 한약재로 이루어진 한약재분말을 혼합하면 옻나무가 갖고 있는 특유의 독성이 한약재분말에 의하여 중화되어 옻나무의 약효와 한약재분말의 약효가 서로 상승작용을 일으켜 인체에 유익한 효능을 구현할 수 있다.
The mixture manufacturing step (S30) is a process of mixing the lacquer powder made in the lacquer powder manufacturing step (S10) and the herbal medicine powder made in the herbal powder manufacturing step (S20) in a weight ratio of 1: 1 to make a mixture. Thus, mixing the lacquer powder and the medicinal herb powder composed of a plurality of herbal medicines can neutralize the specific toxicity of the lacquer tree by the herbal medicine powder, so that the medicinal effect of the lacquer tree and the medicinal herb powder can synergize with each other to realize beneficial effects on the human body. .
상기 티백포장단계(S40)는 상기 혼합물 제조단계(S30)에서 만들어진 혼합물을 티백에 수납하는 과정이다.The tea bag packaging step (S40) is a process of storing the mixture made in the mixture manufacturing step (S30) in a tea bag.
티백포장단계(S40)에서는 가로세로 62.5×50mm의 소형티백과 가로세로 85×75mm의 대형티백이 사용된다. 소형티백에는 12g의 혼합물이 투입되고, 대형티백에는 20g의 혼합물이 투입된다. 이렇게 혼합물이 투입된 소형티백과 대형티백은 끓는 물에 넣어서 그것을 우려낸 물을 식수로 사용할 수도 있다. In the tea bag packaging step (S40), a small tea bag having a width of 62.5 × 50 mm and a large tea bag having a width of 85 × 75 mm are used. 12 g of the mixture is added to the small tea bag and 20 g of the mixture is added to the large tea bag. The small tea bags and large tea bags in which the mixture is added may be put in boiling water and used as drinking water.
여기서, 상기 티백포장단계(S40)에서 제조된 티백, 그 중에서 대형티백을 육계(肉鷄)에 동봉하여 포장함으로써 육계를 조리하는 소비자들의 편의를 도울 수 있다.
Here, the tea bags manufactured in the tea bag packaging step (S40), the large tea bags of the enclosed in the broiler (肉鷄) can be packed to help the convenience of consumers cooking broilers.
한편, 상기와 같은 방법으로 제조된 본 발명의 옻티백 효능을 시험하기 위하여 다음과 같은 실험을 실시하였다.On the other hand, the following experiment was carried out to test the lacquer bag efficacy of the present invention prepared by the method as described above.
먼저, 옻나무 분말 10g을 티백에 넣어, 100℃이상 가열한 물 2L에 10분간 투입하여 옻나무의 성분이 추출된 용액 10g을 20세 이상의 성인남자에게 시음토록 한 후, 신체에 나타나는 반응을 관찰한 결과 심한 피부소양감과 함께 발진 발열, 홍반 등의 반응을 나타내었다.First, 10g of lacquer powder was put into a tea bag, and 10g of the solution of the lacquer extract was added to 2L of water heated at 100 ° C or more for 10 minutes. In addition to severe skin rash, rash, fever, erythema, etc.
다음으로, 20세 이상의 성인 남녀 40명에게 본 발명에 의한 방법으로 제작된 옻티백, 즉 천궁, 하수오, 공사인, 산사자, 숙지황, 토사자, 백복령, 원지, 복분자, 녹차 및 감초 등 총 11종의 한약재분말 10g과 옻나무분말 10g을 포함한 옻티백을 100℃이상 가열한 물 2L에 투입, 10분이 경과한 후, 이 물 10g을 시음토록 한 후, 이들에게 나타나는 반응을 관찰한 결과 전원이 무독성 반응을 나타내었다.Next, a total of 11 kinds of lacquer tea bags made by the method according to the present invention, namely Cheonggung, Shouo, construction workers, mountain lions, Sujijihwang, earthenware, Baekbokryeong, Wonji, Bokbunja, green tea and licorice. After adding 10g of Chinese herbal medicine powder and 10g lacquer powder to 2L of water heated to 100 ℃ or more, after 10 minutes, tasting 10g of this water and observing the reaction appearing in them, all of them showed no toxic reaction. Indicated.
이러한 실험결과를 통하여 본 발명에 의한 옻티백 제조방법에 의하여 만들어진 옻티백 내부에 포함된 옻나무분말은 11가지의 한약재에 의하여 중화되었음을 알 수 있다.Through these experimental results, it can be seen that the lacquer powder contained in the lacquer bag made by the lacquer tea bag manufacturing method according to the present invention was neutralized by 11 kinds of herbal medicines.
상기한 11가지의 한약재(천궁, 하수오, 공사인, 산사자, 숙지황, 토사자, 백복령, 원지, 복분자, 녹차 및 감초)는 개별적으로는 옻나무의 독성을 제거하는 효능을 갖고 있지 않지만, 이들이 혼합되어 100℃이상의 물에서 가열되는 과정에서 상호 상승작용을 일으켜 옻나무의 독성을 제거한다.
The eleven herbs mentioned above (Cheongung, Shouo, Koksan, Sansa, Sukjihwang, Tosa, Baekbokryeong, Wonji, Bokbunja, Green Tea and Licorice) are not individually effective in eliminating the toxicity of lacquer trees, but they are mixed 100 In the process of heating in water above ℃ ℃ synergism to remove the poison of the sumac.
S10: 옻나무분말 제조단계 S20: 한약재분말 제조단계
S30: 혼합물 제조단계 S40: 티백포장단계S10: lacquer powder manufacturing step S20: Chinese medicine powder manufacturing step
S30: Mixture manufacturing step S40: Tea bag packaging step
Claims (2)
천궁, 하수오, 공사인, 산사자, 숙지황, 토사자, 백복령, 원지, 복분자, 녹차 및 감초를 건조한 후 분쇄하여 한약재분말을 만드는 한약재분말 제조단계(S20)와;
상기 옻나무분말 제조단계(S10)에서 만들어진 옻나무분말과 상기 한약재분말 제조단계(S20)에서 만들어진 한약재분말을 1:1의 중량비로 혼합하여 혼합물을 만드는 혼합물 제조단계(S30)와;
상기 혼합물 제조단계(S30)에서 만들어진 혼합물을 티백에 수납하는 티백포장단계(S40);로 구성된 것을 특징으로 하는 옻티백 제조방법.
Lacquer powder manufacturing step (S10) of making a lacquer powder by drying and then crushing the wood, roots, seeds and leaf stem of the lacquer;
Chinese herbal medicine powder manufacturing step (S20) of making medicinal herb powder by drying and pulverizing Cheongung, sewage, construction worker, mountain lion, Sujijihwang, earthenware, Baekbokyeong, Wonji, Bokbunja, green tea and licorice;
A mixture manufacturing step (S30) of mixing the lacquer powder made in the lacquer powder manufacturing step (S10) and the herbal medicine powder made in the herbal medicine powder manufacturing step (S20) in a weight ratio of 1: 1;
Lac tea bag manufacturing method characterized in that consisting of; tea bag packaging step (S40) for receiving the mixture made in the mixture manufacturing step (S30) in a tea bag.
상기 한약재분말 제조단계(S30)에서 천궁, 하수오, 공사인, 산사자, 숙지황, 토사자, 백복령, 원지, 복분자, 녹차 및 감초는 각각 동일한 중량이 건조되어 분쇄되는 것을 특징으로 하는 옻티백 제조방법.The method according to claim 1,
The Chinese herbal medicine powder manufacturing step (S30) in Cheonggung, sewage, construction workers, mountain lions, sukjihwang, earthenware, baekbokyeong, Wonji, Bokbunja, green tea and licorice each lacquer bag manufacturing method characterized in that the same weight is dried and crushed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110063621A KR101217944B1 (en) | 2011-06-29 | 2011-06-29 | A manufacturing method of lacquer tea bag |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110063621A KR101217944B1 (en) | 2011-06-29 | 2011-06-29 | A manufacturing method of lacquer tea bag |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR101217944B1 true KR101217944B1 (en) | 2013-01-02 |
Family
ID=47841039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020110063621A KR101217944B1 (en) | 2011-06-29 | 2011-06-29 | A manufacturing method of lacquer tea bag |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101217944B1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150090530A (en) * | 2014-01-29 | 2015-08-06 | (주)비락지엔비 | Method for preparing sumac extract |
| KR20160082568A (en) | 2014-12-30 | 2016-07-08 | 김옥순 | Composition comprising Rhus verniciflua for extraction and extraction mthod of the Composition |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020023439A (en) * | 2000-09-21 | 2002-03-29 | 김중배 | Method for Extracting the Extra ct of Detoxicated Rhus Verniciflua |
| KR100832056B1 (en) | 2006-11-30 | 2008-05-27 | 유화열 | The tea-bag of lacquer and method of producing it |
-
2011
- 2011-06-29 KR KR1020110063621A patent/KR101217944B1/en not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020023439A (en) * | 2000-09-21 | 2002-03-29 | 김중배 | Method for Extracting the Extra ct of Detoxicated Rhus Verniciflua |
| KR100832056B1 (en) | 2006-11-30 | 2008-05-27 | 유화열 | The tea-bag of lacquer and method of producing it |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150090530A (en) * | 2014-01-29 | 2015-08-06 | (주)비락지엔비 | Method for preparing sumac extract |
| KR101661390B1 (en) * | 2014-01-29 | 2016-09-29 | 한영선 | Method for preparing sumac extract by reducing urushiol with green tea |
| KR20160082568A (en) | 2014-12-30 | 2016-07-08 | 김옥순 | Composition comprising Rhus verniciflua for extraction and extraction mthod of the Composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kumar et al. | Recent trends in potential traditional Indian herbs Emblica officinalis and its medicinal importance | |
| Singh et al. | Phytochemistry, traditional uses and cancer chemopreventive activity of Amla (Phyllanthus emblica): The Sustainer | |
| KR100472052B1 (en) | Cosmetic composition using fermentation of natural herb medicine | |
| KR20110054579A (en) | Herbal medicine composite and pill for ophthalmic fatigue relief and eyesight recovery | |
| CN102113599A (en) | Eucommia bark and honeysuckle tea and preparation method thereof | |
| CN103816292B (en) | Traditional Chinese medicine foot bath powder and preparation method thereof | |
| KR101217944B1 (en) | A manufacturing method of lacquer tea bag | |
| KR101497226B1 (en) | Method for making products containing korean composition material | |
| KR101338560B1 (en) | Method for manufacturing a health noodles oriental medicine composition and mulberry is contained | |
| KR20150137506A (en) | A composition comprising medical herbs for improving urologic function and manufacturing method thereof | |
| KR100780552B1 (en) | Milk for the baby comprising medicalherbs and method preparing thereof | |
| CN105031408A (en) | Health product for improving gout | |
| CN100548269C (en) | Medicine bath shampoo for health preserving and moisturizing skin | |
| KR20120024186A (en) | A composition of health supplementary food and method thereof | |
| KR100668053B1 (en) | Manufacturing method of health food using medicinal duck | |
| CN106727967A (en) | Chinese yew lavipeditum powder and preparation method | |
| KR20170064672A (en) | Herb bath liquid and manufacturing method thereof | |
| CN103315085A (en) | Health-preserving tea | |
| CN104095457A (en) | Drug pillow with effect of treating premature graying | |
| CN109043045A (en) | A kind of Dandelion health-preservation tea and preparation method thereof | |
| KR101652507B1 (en) | Herbal Medicine Composition and Pill for Ophthalmic Health | |
| CN103705044A (en) | Medicine pillow for treating pre-senile poliosis | |
| KR101147288B1 (en) | Oral hair growth composition from medical plant extracts and process for preparing thereof | |
| KR20110112270A (en) | Manufacturing method of oral taking treatment for hair growth solution extracts from medical plants | |
| Mishra et al. | A REVIEW OF IMPORTANT FACTS DESCRIBE IN AYURVEDA WHILE CONSUMPTION OF HONEY FOR HEALTH BENEFITS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| LAPS | Lapse due to unpaid annual fee |